Luminex Corporation Announces Group B Streptococcus (GBS), as a Launch Menu Assay for its New Sample-to-Answer System, ARIESâ„¢

Luminex Corporation Announces Group B Streptococcus (GBS), as a Launch Menu Assay for its New Sample-to-Answer System, ARIESâ„¢

[PR Newswire] – AUSTIN, Texas, May 12, 2014 /PRNewswire/ — Luminex Corporation (LMNX) today announced that Group B Streptococcus (group B strep, GBS) is the fifth assay planned for the launch menu of its new sample-to-answer system, ARIESâ„¢. The assay more

View todays social media effects on LMNX

View the latest stocks trending across Twitter. Click to view dashboard

See who Luminex is hiring next, click here to view

Share this post